Renaissance Technologies’s CRH Medical Corporation CRHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,126,185
Closed -$4.45M 3934
2021
Q1
$4.45M Sell
1,126,185
-59,900
-5% -$194K 0.01% 1719
2020
Q4
$2.76M Sell
1,186,085
-86,400
-7% -$212K ﹤0.01% 1936
2020
Q3
$2.76M Buy
1,272,485
+67,000
+6% +$156K ﹤0.01% 1929
2020
Q2
$2.5M Sell
1,205,485
-348,500
-22% -$704K ﹤0.01% 2059
2020
Q1
$2.08M Buy
1,553,985
+631,562
+68% +$2.06M ﹤0.01% 2030
2019
Q4
$3.2M Buy
922,423
+236,823
+35% +$748K ﹤0.01% 2097
2019
Q3
$2.11M Buy
685,600
+15,900
+2% +$47.2K ﹤0.01% 2253
2019
Q2
$2.03M Buy
669,700
+22,500
+3% +$64.4K ﹤0.01% 2323
2019
Q1
$1.72M Buy
647,200
+39,358
+6% +$121K ﹤0.01% 2385
2018
Q4
$1.85M Sell
607,842
-72,558
-11% -$239K ﹤0.01% 2275
2018
Q3
$2.69M Buy
680,400
+296,800
+77% +$1.09M ﹤0.01% 2135
2018
Q2
$1.19M Buy
383,600
+120,800
+46% +$385K ﹤0.01% 2525
2018
Q1
$670K Sell
262,800
-35,400
-12% -$99.3K ﹤0.01% 2812
2017
Q4
$790K Sell
298,200
-120,900
-29% -$270K ﹤0.01% 2751
2017
Q3
$1.09M Sell
419,100
-4,120
-1% -$12.7K ﹤0.01% 2544
2017
Q2
$2.41M Buy
423,220
+121,920
+40% +$791K ﹤0.01% 2151
2017
Q1
$2.47M Buy
301,300
+110,700
+58% +$765K ﹤0.01% 2124
2016
Q4
$1M Sell
190,600
-41,300
-18% -$209K ﹤0.01% 2537
2016
Q3
$892K Buy
231,900
+109,900
+90% +$420K ﹤0.01% 2621
2016
Q2
$476K Sell
122,000
-9,300
-7% -$30.4K ﹤0.01% 2809
2016
Q1
$433K Buy
+131,300
New +$376K ﹤0.01% 2880

Renaissance Technologies's CRHM Position: Q2 2021 in Review

Renaissance Technologies sold out of CRH Medical Corporation (CRHM) in Q2 2021, closing a stake of 1,126,185 shares — an estimated $4.45M sold.

Renaissance Technologies first reported a position in CRHM in Q1 2016 and held it in 21 quarters. The position peaked at $4.45M in Q1 2021. 1 fund tracked by Wall St. Rank holds CRHM as of Q2 2021.

  • Renaissance Technologies reported no remaining CRH Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Renaissance Technologies sold 1,126,185 CRH Medical Corporation shares in Q2 2021, an estimated $4.45M.
  • Renaissance Technologies first reported a position in CRH Medical Corporation in Q1 2016 and held it in 21 quarters.
  • Renaissance Technologies's CRH Medical Corporation position peaked at $4.45M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2021.

Based on Renaissance Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.